Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Undem

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1993
Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipramD C Underwood, R R Osborn, L B Novak, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivityD Aharony, C K Buckner, J L Ellis, et al.
Agents and Actions|June 1, 1986
The development of Wy-41,195, an orally effective antiallergic drug in animal modelsA J Lewis, R P Carlson, T J Forster, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1993
Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipramD C Underwood, R R Osborn, L B Novak, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivityD Aharony, C K Buckner, J L Ellis, et al.
Agents and Actions|June 1, 1986
The development of Wy-41,195, an orally effective antiallergic drug in animal modelsA J Lewis, R P Carlson, T J Forster, et al.
Pageof 13